Diabetes
Conference Coverage
Tirzepatide’s benefits expand: Lean mass up, serum lipids down
New results from the SURMOUNT-1 trial of tirzepatide in people with obesity show further positive effects.
News
New advice on artificial pancreas insulin delivery systems
A new consensus statement covers the benefits, limitations, and challenges of automated insulin delivery systems and provides recommendations for...
Conference Coverage
Dapagliflozin DELIVERs regardless of systolic pressure in HFpEF
The finding may alleviate long-standing concerns that starting modestly diuretic SGLT2 inhibitors in patients with heart failure might present a...
News
Bariatric surgery prompts visceral fat reduction, cardiac changes
Weight loss after bariatric surgery was tied to favorable cardiac effects associated with reduction in visceral fat.
Expert Perspective
Type 2 Diabetes in Adolescents: We Must Do Better
News
Newer drugs not cost effective for first-line diabetes therapy
Costs of SGLT2 inhibitors and GLP-1 receptor agonists ‘need to be lowered substantially’ to improve health outcomes and prevent health disparities...
News
Food insecurity a growing problem for many with CVD
The number of Americans with cardiovascular disease who have limited or uncertain access to food has more than doubled over the last 20 years.
News
Balanced fat intake links with less type 2 diabetes
Chinese adults whose diet balanced their animal- and vegetable-fat intake had a significantly lower incidence of type 2 diabetes, compared with...
Conference Coverage
How to improve diagnosis of HFpEF, common in diabetes
Heart failure with preserved ejection fraction is common in people with type 2 diabetes but is often hard to recognize. Treatments newly proven to...
Conference Coverage
Once-weekly insulin promising in phase 3 trial in type 2 diabetes
Novo Nordisk’s insulin icodec was superior in lowering A1c compared with daily degludec without increasing the risk for moderate or severe...